National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Enzalutamide Research Grant Opportunity Submit by April 27, 2015
Study Proposal Submission-NCCN RMS
NCCN ORP Recent News
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN ORP Grant History
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

NCCN ORP Drug Pipeline Review Research Services

The NCCN ORP establishes Scientific Advisory Boards (SABs) to provide advice and direction to industry collaborators developing new and innovative oncology drugs and biologics. SABs are made up of notable academic scientific, clinical, and pharmacy experts in oncology. Each SAB is unique with leading experts specifically matched to the drug development plans and strategies of the company. The principal mission of each SAB includes:

  • reviewing the quality and relevance of the scientific and technical information being used or proposed as the basis for drug development
  • assisting in advancing the development of preclinical and clinical-stage product candidates
  • reviewing research programs and advising Industry on specific clinical and scientific matters related to oncology drug development
  • assisting in developing an academic and industry approach to drug development